Financials

  • Market Capitalization 11.69 B
  • Employee 925
  • Founded 2012
  • CEO Herriot Tabuteau
  • Website www.axsome.com
  • Headquarter Delaware, United States
  • FIGI BBG00B6G7GL7
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-49.63
Price to sales ratio
14.23

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
805
MDGL
Madrigal Pharmaceuticals, Inc. - Common Stock
529.67 USD-1.31%+0.46%+11.68%+25.04%12.21 B USD
825
SMMT
Summit Therapeutics Inc. - Common Stock
14.85 USD-2.62%-4.69%+14.23%-25.23%11.53 B USD
846
BMRN
BioMarin Pharmaceutical Inc. - Common Stock
58.79 USD-0.56%+0.24%+5.85%+1.33%11.36 B USD
861
TECH
Bio-Techne Corp - Common Stock
71.37 USD+0.10%+0.65%+32.02%+32.98%11.17 B USD

Frequently asked questions about Axsome Therapeutics, Inc. - Common Stock

What is the Axsome Therapeutics, Inc. - Common Stock stock price today?

The current price of Axsome Therapeutics, Inc. - Common Stock (AXSM) is 227.21. Over the past 24 hours, the stock has changed by -2.82%. Follow the AXSM chart for real-time price dynamics.

What is the stock ticker of Axsome Therapeutics, Inc. - Common Stock?

Axsome Therapeutics, Inc. - Common Stock trades under the ticker AXSM. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Axsome Therapeutics, Inc. - Common Stock stock going up?

AXSM has changed by -5.49% over the last week, -10.21% over the last month, and +74.51% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Axsome Therapeutics, Inc. - Common Stock net income for the last quarter?

Axsome Therapeutics, Inc. - Common Stock reported net income of -64.54 M for the last quarter. The previous quarter showed -28.56 M, which means net income changed by -126.00%.

How many employees does Axsome Therapeutics, Inc. - Common Stock have?

As of the latest available data, Axsome Therapeutics, Inc. - Common Stock has 925 employees. Workforce size can provide additional context about the company's scale and operations.

What is Axsome Therapeutics, Inc. - Common Stock EBITDA?

Axsome Therapeutics, Inc. - Common Stock EBITDA is -60.83 M, and its EBITDA margin is -31.81%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Axsome Therapeutics, Inc. - Common Stock stock?

You can buy Axsome Therapeutics, Inc. - Common Stock (AXSM) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Axsome Therapeutics, Inc. - Common Stock stock?

Investing in Axsome Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the AXSM chart and related analysis on metatrader.com as part of your research.

News